The lymphoid environment of the tonsil oral MALT makes these tissues highly susceptible to infection and establishment of HIV reservoirs45,46; however, CD4+ T cell dysfunction in relation to oral residual immune activation in cART-treated patients has not been studied before. This evidence concerns the gene CD4 and infection.